Skip to content

Comprehensive Geriatric Assessment in Kidney Transplantation

Comprehensive Geriatric Assessment in Kidney Transplantation

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06104696
Acronym
CoGeriaTx
Enrollment
1000
Registered
2023-10-27
Start date
2020-01-02
Completion date
2040-01-02
Last updated
2023-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depressive Syndrome, Frailty Syndrome, Kidney Transplant; Complications

Keywords

kidney transplantation, geriatric, frailty, depression, pretransplant evaluation, comprehensive geriatric assessment, posttransplant

Brief summary

This observational study aims to analyze the results of comprehensive geriatric assessment and to monitor the development of functional status in geriatric kidney transplant candidates and recipients.

Detailed description

Kidney transplantation represents the best therapeutical option in patients in end stage kidney disease. At present, increasing number of older patients are referred for kidney transplantation. Patients' functional status has been shown to be associated with transplant outcomes. The comprehensive geriatric assessment (CGA) of functional and mental status in older kidney transplant candidates might play an important and supportive role in the pre-transplant evaluation process, including acceptance for transplantation. In kidney transplant recipients, this examination might be useful to evaluate the impact of pre-transplant status on post-transplant course. Also in KTR, CGA may contribute to the improvement of functional status and quality of life independently from the graft function.

Interventions

Examination of physical and mental status using standardized tests.

Sponsors

Institute for Clinical and Experimental Medicine
Lead SponsorOTHER_GOV

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
60 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* kidney transplant candidates aged 60+ years * kidney transplant recipients aged 60+ years

Exclusion criteria

* kidney transplant candidates aged below 60 years * kidney transplant recipients aged below 60 years

Design outcomes

Primary

MeasureTime frameDescription
Frailty syndrome (Fried frailty phenotype)2020-2040Geriatric assessment of frailty syndrome in kidney transplant candidates and recipients. Evaluation of frailty syndrome based on Fried frailty phenotype, Short Physical Performance Battery (SPPB) and complex comprehensive geriatric assessment including cognitive frailty (Montreal Cognitive Assessment MoCA).
Acceptance for kidney transplantation (Number of patients listed for kidney transplantation and number of transplanted patients)2020-2040Acceptance for kidney transplantation based on both geriatric and nephrologic evaluation. Number of patients listed for kidney transplantation,number of transplanted patients and number of patients not accepted for transplantation.
Outcomes of kidney transplantation (Graft and patient surival, number of patients with related adverse events)2020-2040Outcomes of kidney transplantation based on both geriatric and nephrologic evaluation. Short- and long-term patient and graft survival, graft function, post-transplant related adverse events (infection rate, MACE, death, days of hospitalisation).
Functional status evaluated by comprehensive geriatric assessment2020-2040Functional status evaluated by comprehensive geriatric assessment in geriatric kidney transplant candidates and recipients including evaluation of mobility (Short Physical Performance Battery, SPPB, walking speed m/s, muscle strenght measured by hand-grip) and cognition (Montreal Cognitive Assessment, MoCA), self-sufficiency and/or dysability (Activities of Daily Living, ADL, Instrumental Activities of Daily Living, IADL).
Depressive syndrome (amount of depressive symptoms measured by GDS scale)2020-2040Depressive syndrome in geriatric kidney transplant candidates and recipients. amount of depressive symptoms measured by GDS (Geriatric Depression Scale) scale by Yesavage.

Countries

Czechia

Contacts

Primary ContactSilvie Rajnochova Bloudickova, MD,PhD
sibl@ikem.cz261362223
Backup ContactHana Vankova, MD,PhD
ha.van@seznam.cz261362223

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026